NovoLog and Ranibizumab ophthalmic
Determining the interaction of NovoLog and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: NovoLog, NovoLog FlexPen, NovoLog PenFill, Fiasp, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Novolog
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog-Ranitidine
- NovoLog-Ranitidine Capsule
- NovoLog-Ranitidine Hydrochloride
- NovoLog-Ranitidine Injection
- NovoLog-Ranitidine Suspension
- NovoLog-Ranitidine Syrup
- Ranibizumab ophthalmic-NovoLog FlexPen
- Ranibizumab ophthalmic-Novolog Injection
- Ranibizumab ophthalmic-NovoLog Mix 70/30
- Ranibizumab ophthalmic-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Ranibizumab ophthalmic-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Ranibizumab ophthalmic-NovoLog Mix 70/30 FlexPen